Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$8.12 USD
-0.18 (-2.17%)
Updated May 3, 2024 04:00 PM ET
After-Market: $8.11 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Brokerage Reports
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 881 - 900 ( 1015 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov. 22
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov. 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Oct. 25
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ending Oct. 18
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q3:13 Update - Linzess Sales Miss Our and the StreetÂ’s Expectation; Lowering Price Target to $10 from $12 -Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G